ArticleCNS drugs2022

Comment on: "A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention Deficit/Hyperactivity Disorder".

Alok Singh et al.PubMed ↗Publisher ↗

No numbers read from the abstract.